Literature DB >> 22947274

Comparison of semi-automatic volumetric VX2 hepatic tumor segmentation from cone beam CT and multi-detector CT with histology in rabbit models.

Olivier Pellerin1, Mingde Lin, Nikhil Bhagat, Roberto Ardon, Benoit Mory, Jean-François Geschwind.   

Abstract

RATIONALE AND
OBJECTIVES: The purpose of this study was to compare tumor volume in a VX2 rabbit model as calculated using semiautomatic tumor segmentation from C-arm cone-beam computed tomography (CBCT) and multidetector computed tomography (MDCT) to the actual tumor volume.
MATERIALS AND METHODS: Twenty VX2 tumors in 20 adult male New Zealand rabbits (one tumor per rabbit) were imaged with CBCT (using an intra-arterial contrast medium injection) and MDCT (using an intravenous contrast injection). All tumor volumes were measured using semiautomatic three-dimensional volumetric segmentation software. The software uses a region-growing method using non-Euclidean radial basis functions. After imaging, the tumors were excised for pathologic volume measurement. The imaging-based tumor volume measurements were compared to the pathologic volumes using linear regression, with Pearson's test, and correlated using Bland-Altman analysis.
RESULTS: Average tumor volumes were 3.5 ± 1.6 cm(3) (range, 1.4-7.2 cm(3)) on pathology, 3.8 ± 1.6 cm(3) (range, 1.3-7.3 cm(3)) on CBCT, and 3.9 ± 1.6 (range, 1.8-7.5 cm(3)) on MDCT (P < .001). A strong correlation between volumes on pathology and CBCT and also with MDCT was observed (Pearson's correlation coefficient = 0.993 and 0.996, P < .001, for CBCT and MDCT, respectively). Bland-Altman analysis showed that MDCT tended to overestimate tumor volume, and there was stronger agreement for tumor volume between CBCT and pathology than with MDCT, possibly because of the intra-arterial contrast injection.
CONCLUSIONS: Tumor volume as measured using semiautomatic tumor segmentation software showed a strong correlation with the "real volume" measured on pathology. The segmentation software on CBCT and MDCT can be a useful tool for volumetric hepatic tumor assessment.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22947274      PMCID: PMC3575098          DOI: 10.1016/j.acra.2012.07.011

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  17 in total

Review 1.  Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures.

Authors:  H K Lim; J K Han
Journal:  Abdom Imaging       Date:  2002 Mar-Apr

2.  Tumor size on computed tomography scans: is one measurement enough?

Authors:  A H Dachman; P M MacEneaney; A Adedipe; M Carlin; L P Schumm
Journal:  Cancer       Date:  2001-02-01       Impact factor: 6.860

3.  CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.

Authors:  Srinivasa R Prasad; Kartik S Jhaveri; Sanjay Saini; Peter F Hahn; Elkan F Halpern; James E Sumner
Journal:  Radiology       Date:  2002-11       Impact factor: 11.105

4.  Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria.

Authors:  Chikako Suzuki; Michael R Torkzad; Hans Jacobsson; Gunnar Aström; Anders Sundin; Thomas Hatschek; Hirofumi Fujii; Lennart Blomqvist
Journal:  Acta Oncol       Date:  2010-05       Impact factor: 4.089

5.  Some suggestions for measuring predictive performance.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

6.  Liver tumour segmentation using contrast-enhanced multi-detector CT data: performance benchmarking of three semiautomated methods.

Authors:  Jia-Yin Zhou; Damon W K Wong; Feng Ding; Sudhakar K Venkatesh; Qi Tian; Ying-Yi Qi; Wei Xiong; Jimmy J Liu; Wee-Kheng Leow
Journal:  Eur Radiol       Date:  2010-02-16       Impact factor: 5.315

7.  Percutaneous US-guided implantation of Vx-2 carcinoma into rabbit liver: a comparison with open surgical method.

Authors:  Kwang-Hun Lee; Eleni Liapi; Manon Buijs; Josephina Anna Vossen; Veronica Prieto-Ventura; Labiq H Syed; Jean-Francois H Geschwind
Journal:  J Surg Res       Date:  2008-09-29       Impact factor: 2.192

8.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

9.  Semi-automated measurement of hyperdense, hypodense and heterogeneous hepatic metastasis on standard MDCT slices. Comparison of semi-automated and manual measurement of RECIST and WHO criteria.

Authors:  Sebastian Keil; Florian F Behrendt; Sven Stanzel; Michael Sühling; Alexander Koch; Jhenee Bubenzer; Georg Mühlenbruch; Andreas H Mahnken; Rolf W Günther; Marco Das
Journal:  Eur Radiol       Date:  2008-06-04       Impact factor: 5.315

10.  Comparing the detectability of hepatocellular carcinoma by C-arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging.

Authors:  Romaric Loffroy; MingDe Lin; Pramod Rao; Nikhil Bhagat; Niels Noordhoek; Alessandro Radaelli; Järl Blijd; Jean-François Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2011-02-17       Impact factor: 2.797

View more
  26 in total

1.  Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?

Authors:  Olivier Pellerin; Helena Pereira; Claire Van Ngoc Ty; Nadia Moussa; Costantino Del Giudice; Simon Pernot; Carole Déan; Gilles Chatellier; Marc Sapoval
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

2.  Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

Authors:  Yan Zhao; Rafael Duran; Wei Bai; Sonia Sahu; Wenjun Wang; Sven Kabus; MingDe Lin; Guohong Han; Jean-François Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2017-10-30       Impact factor: 2.740

3.  Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.

Authors:  Zhijun Wang; Rongxin Chen; Rafael Duran; Yan Zhao; Gayane Yenokyan; Julius Chapiro; Rüdiger Schernthaner; Alessandro Radaelli; MingDe Lin; Jean-François Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2015-05-23       Impact factor: 2.740

4.  Three-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; John D Werner; Zhijun Wang; Rüdiger Schernthaner; Lynn Jeanette Savic; Mark L Lessne; Jean-François Geschwind; Kelvin Hong
Journal:  J Vasc Interv Radiol       Date:  2015-01-28       Impact factor: 3.464

5.  Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; Rüdiger Schernthaner; David Lesage; Zhijun Wang; Lynn Jeanette Savic; Jean-François Geschwind
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

6.  The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma.

Authors:  Susanne Smolka; Julius Chapiro; Wilfred Manzano; John Treilhard; Eric Reiner; Yanhong Deng; Yan Zhao; Bernd Hamm; James S Duncan; Bernhard Gebauer; MingDe Lin; Jean-François Geschwind
Journal:  Clin Imaging       Date:  2017-06-07       Impact factor: 1.605

7.  Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.

Authors:  Arun Chockalingam; Rafael Duran; Jae Ho Sohn; Rüdiger Schernthaner; Julius Chapiro; Howard Lee; Sonia Sahu; Sonny Nguyen; Jean-François Geschwind; MingDe Lin
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

8.  Dual-phase cone-beam computed tomography to see, reach, and treat hepatocellular carcinoma during drug-eluting beads transarterial chemo-embolization.

Authors:  Vania Tacher; Mingde Lin; Nikhil Bhagat; Nadine Abi Jaoudeh; Alessandro Radaelli; Niels Noordhoek; Bart Carelsen; Bradford J Wood; Jean-François Geschwind
Journal:  J Vis Exp       Date:  2013-12-02       Impact factor: 1.355

9.  Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.

Authors:  Rongxin Chen; Jean-François Geschwind; Zhijun Wang; Vania Tacher; MingDe Lin
Journal:  J Vasc Interv Radiol       Date:  2013-10-01       Impact factor: 3.464

10.  Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI.

Authors:  Vania Tacher; MingDe Lin; Michael Chao; Lars Gjesteby; Nikhil Bhagat; Abdelkader Mahammedi; Roberto Ardon; Benoit Mory; Jean-François Geschwind
Journal:  Acad Radiol       Date:  2013-04       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.